tiprankstipranks
pc:memed

MeMed

MeMed is a diagnostics company focused on host-response testing that translates immune system signals into clinical insights for acute and infectious diseases. The company develops rapid, FDA-grade host-response tests and AI-enabled diagnostics (AIVD) to distinguish bacterial from viral infections and predict severe outcomes, and is building an acute-care biobank and proteomics platform to support AI-driven diagnostic development.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$2M
Total Amount Raised$2M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$2M
Latest Funding Amount$2M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 12, 2026
Investment
$2.00M

Investors

Investor Name
Funding Round

Related News and Analysis